Lobbying client

EGALET CORPORATION

Pharmaceutical company that develops and commercializes abuse-deterrent formulations.

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
16
Filed by
2
Reported in-house
—
Reported by firms
$460,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2016 to 2019

Filings

6 filings for 2016, newest first.
Filing Filed by Amount
4th Quarter - Report
4th Quarter 2016
BGR GOVERNMENT AFFAIRS $30,000 reported
3rd Quarter - Amendment
3rd Quarter 2016
BGR GOVERNMENT AFFAIRS $30,000 reported
3rd Quarter - Reportreplaced
3rd Quarter 2016
BGR GOVERNMENT AFFAIRS $30,000 reported
2nd Quarter - Report
2nd Quarter 2016
BGR GOVERNMENT AFFAIRS $30,000 reported
1st Quarter - Report
1st Quarter 2016
BGR GOVERNMENT AFFAIRS $30,000 reported
Registration
1st Quarter 2016
BGR GOVERNMENT AFFAIRS — reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
THE MCMANUS GROUP 7 $310,000
BGR GOVERNMENT AFFAIRS 6 $150,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 14
Medicare/Medicaid MMM 3

Bills named in its filings

Bill numbers found in the filers' descriptions, most often named first.

BillCongressTimes named
H.R. 5582 115th 3
H.R. 6 115th 2

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.